Olga Lomovskaya (O Lomovskaya)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Respiratory Tract

Pseudomonas Aeruginosa

Multidrug Resistant

Top Venues

Antimicrobial agents and chemotherapy

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Wang, Sylvia A Sapula, Jonathan J Whittall, Jack M Blaikie, Olga Lomovskaya, Henrietta Venter
Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics. Communications biology 7 (1) (2024)
Yu Wang, Sylvia A Sapula, Jonathan J Whittall, Jack M Blaikie, Olga Lomovskaya, Henrietta Venter
Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics. Communications biology 7 (1) (2024)
Yu Wang, Sylvia A Sapula, Jonathan J Whittall, Jack M Blaikie, Olga Lomovskaya, Henrietta Venter
Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics. Communications biology 7 (1) (2024)
Yu Wang, Sylvia A Sapula, Jonathan J Whittall, Jack M Blaikie, Olga Lomovskaya, Henrietta Venter
Identification and characterization of CIM-1, a carbapenemase that adds to the family of resistance factors against last resort antibiotics. Communications biology 7 (1) (2024)
Olga Lomovskaya, Ruslan Tsivkovski, Maxim Totrov, Dana Dressel, Mariana Castanheira, Michael Dudley
New boronate drugs and evolving NDM-mediated beta-lactam resistance. Antimicrobial agents and chemotherapy (2023)
Olga Lomovskaya, Mariana Castanheira, Jill Lindley, Debora Rubio-Aparicio, Kirk Nelson, Ruslan Tsivkovski, Dongxu Sun, Maxim Totrov, Jeffery Loutit, Michael Dudley
In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales . Antimicrobial agents and chemotherapy (2023)
Silvia Gervasoni, Jitender Mehla, Charles R Bergen, Inga V Leus, Enrico Margiotta, Giuliano Malloci, Andrea Bosin, Attilio V Vargiu, Olga Lomovskaya, Valentin V Rybenkov, Paolo Ruggerone, Helen I Zgurskaya
Molecular determinants of avoidance and inhibition of Pseudomonas aeruginosa MexB efflux pump. mBio (2023)
Sujata M Bhavnani, Michael Trang, David C Griffith, Olga Lomovskaya, J P Hammel, J S Loutit, S K Cammarata, M N Dudley, Paul G Ambrose, Christopher M Rubino
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints. Antimicrobial agents and chemotherapy (2022)
Dongxu Sun, Ruslan Tsivkovski, Joe Pogliano, Hannah Tsunemoto, Kirk Nelson, Debora Rubio-Aparicio, Olga Lomovskaya
Intrinsic Antibacterial Activity of Xeruborbactam In Vitro : Assessing Spectrum and Mode of Action. Antimicrobial agents and chemotherapy 66 (10) (2022)
Olga Lomovskaya, Debora Rubio-Aparicio, Kirk Nelson, Dongxu Sun, Ruslan Tsivkovski, Mariana Castanheira, Jill Lindley, Jeffery Loutit, Michael Dudley
In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 65 (6) (2021)
Jitender Mehla, Giuliano Malloci, Rachael Mansbach, Cesar A López, Ruslan Tsivkovski, Keith Haynes, Inga V Leus, Sally B Grindstaff, Robert H Cascella, Napoleon D'Cunha, Liam Herndon, Nicolas W Hengartner, Enrico Margiotta, Alessio Atzori, Attilio Vittorio Vargiu, Pedro D Manrique, John K Walker, Olga Lomovskaya, Paolo Ruggerone, S Gnanakaran, Valentin V Rybenkov, Helen I Zgurskaya
Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa. mBio 12 (1) (2021)
Olga Lomovskaya, Debora Rubio-Aparicio, Ruslan Tsivkovski, Jeff Loutit, Michael Dudley
The Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 Restores the Potency of Multiple Oral Beta-Lactam Antibiotics against Beta-Lactamase-Producing Strains of Resistant Enterobacterales . Antimicrobial agents and chemotherapy 66 (2) (2021)
Kirk Nelson, Debora Rubio-Aparicio, Ruslan Tsivkovski, Dongxu Sun, Maxim Totrov, Michael Dudley, Olga Lomovskaya
In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii. Antimicrobial agents and chemotherapy 64 (11) (2020)